Oligomerization and cellular localization of SLC26A11

Stefanie Bungert-Plümke,Raul E. Guzman,Christoph Fahlke
DOI: https://doi.org/10.1101/2024.04.29.591613
2024-05-01
Abstract:The solute carrier family 26 (SLC26) encompasses multifunctional anion exchangers in all kingdoms of life. SLC26 proteins are known to assemble as dimers, and co-expression of multiple isoforms in certain cells raises the question whether different SLC26s can assemble into hetero-dimers. We focused on SLC26A11, a broadly expressed isoform that differs from other isoforms in its subcellular localization. Whereas the vast majority of SLC26-FP fusion proteins, i.e. SLC26A1, SLC26A2, SlC26A3, SLC26A4/pendrin, SLC26A5/prestin, SLC26A6, SlC26A7, and SLC26A9, localize to the surface membrane of transfected mammalian cells, we found exclusive lysosomal localization of SLC26A11. Renal collecting duct intercalated cells express SLC26A11 together with SLC26A4/pendrin and SLC26A7, and we therefore tested whether heterodimerization between these transporters might result in SLC26 transporter re-localization. Neither in HEK293T nor in immortalized intercalated cells co-expressing SLC26A11 with SLC26A4/pendrin or with SLC26A7, changes of SLC26A11 localization were observed. Moreover, native gel electrophoresis did not provide any evidence for heterodimerization of these isoforms. We next tested heterodimerization of SLC26A11 with SLC26A1, SLC26A2, SLC26A6 or SLC26A9 via co-expression in HEK293T cells and confocal imaging. For all combinations, no changes in subcellular distribution were observed. We conclude that SLC26A11 does not heterodimerize with other SLC26 proteins, and that heterodimerization does not target SLC26A11 to cellular surface membranes.
Cell Biology
What problem does this paper attempt to address?
The paper attempts to address the issues regarding the oligomerization and intracellular localization of the SLC26A11 protein. Specifically: 1. **Intracellular Localization Issue**: The study found that the SLC26A11 protein is primarily localized in lysosomes in transfected mammalian cells, whereas other members of the SLC26 family (such as SLC26A1, SLC26A2, SLC26A3, etc.) are mainly localized on the cell surface membrane. This finding is inconsistent with previous research results, thus requiring further validation. 2. **Hetero-oligomerization Issue**: Since SLC26A11 is co-expressed with other SLC26 family members in certain cell types (such as intercalated cells in the kidney collecting duct), researchers tested whether SLC26A11 could alter its intracellular localization through hetero-oligomerization. Specifically, they tested whether hetero-oligomerization between SLC26A11 and other members like SLC26A4/pendrin or SLC26A7 would cause SLC26A11 to relocate from lysosomes to the cell surface membrane. 3. **Functional Issue**: The function of SLC26A11 is still unclear. Early studies suggested it is an electroneutral sulfate transporter, while later studies reported it might be a chloride ion channel. However, its intracellular localization does not match its presumed function, necessitating further research to determine its actual function. In summary, the main objective of this paper is to experimentally verify the intracellular localization of SLC26A11 and to explore whether it can change its localization through hetero-oligomerization, thereby gaining a better understanding of its function and physiological significance.